ALS Global capabilities (Pharmaceutical)
Brochures and specifications | | ALS EuropeInstrumentation
Reliable pharmaceutical testing and analysis ensure the safety, efficacy and regulatory compliance of drug products. A global, quality-driven laboratory network supports critical decisions in QA/QC and product development.
This document presents the global pharmaceutical testing capabilities of ALS, covering its company profile, quality systems, service portfolio and technical infrastructure.
ALS operates in over 65 countries with 350+ locations and 15 000+ staff, processing more than 40 million samples annually. Its safety performance shows a declining LTIFR trend and a Positive Performance Indicator score of 91 %. Regular audits (100+ per year) and certifications (GLP, GMP, ISO 17025) demonstrate robust quality and compliance.
Clients gain access to an extensive service range and local expertise combined with global technical leadership. Custom reporting formats, electronic data delivery and an online portal facilitate rapid decision-making and supply chain management.
Future directions include automation of workflows, advanced data analytics with AI, expanded multi-element and trace analysis, remote monitoring, digital sample tracking, and deeper integration of LIMS with enterprise systems.
ALS provides a comprehensive, quality-centered platform for pharmaceutical testing, offering regulatory-aligned methodologies, advanced instrumentation, and global support to ensure reliable analytical outcomes.
GC, GC/MSD, HPLC, Ion chromatography, LC/MS, UV–VIS spectrophotometry, ICP/MS, ICP-OES, AAS, Titration, Titration Karl Fischer, FTIR Spectroscopy, Dissolution, Electrochemistry, TOC
IndustriesPharma & Biopharma
ManufacturerSummary
Význam tématu
Reliable pharmaceutical testing and analysis ensure the safety, efficacy and regulatory compliance of drug products. A global, quality-driven laboratory network supports critical decisions in QA/QC and product development.
Cíle a přehled studie / článku
This document presents the global pharmaceutical testing capabilities of ALS, covering its company profile, quality systems, service portfolio and technical infrastructure.
Použitá metodika a instrumentace
- Chromatography: HPLC (UV-Vis, DAD, RI, fluorescence), LC-MS, GC, GC-MS, Ion Chromatography
- Elemental analysis: ICP-MS, ICP-OES, ICP-SFMS, AAS
- Spectroscopy and other techniques: FTIR, UV-Vis spectrophotometry, TOC analyzers, Karl Fischer titration, conductivity, refractive index
- Physical tests: dissolution, hardness, disintegration, friability, dimensions, sub-visible particles
- Microbiology: TAMC, TYMC, endotoxin (LAL), sterility (membrane filtration, direct inoculation), microbial ID by sequencing
- Stability: ICH-compliant stability chambers, photostability testing
- Data management: cGMP and FDA 21 CFR Part 11-compliant LIMS, WebTrieve™ portal
Hlavní výsledky a diskuse
ALS operates in over 65 countries with 350+ locations and 15 000+ staff, processing more than 40 million samples annually. Its safety performance shows a declining LTIFR trend and a Positive Performance Indicator score of 91 %. Regular audits (100+ per year) and certifications (GLP, GMP, ISO 17025) demonstrate robust quality and compliance.
Přínosy a praktické využití metody
Clients gain access to an extensive service range and local expertise combined with global technical leadership. Custom reporting formats, electronic data delivery and an online portal facilitate rapid decision-making and supply chain management.
Budoucí trendy a možnosti využití
Future directions include automation of workflows, advanced data analytics with AI, expanded multi-element and trace analysis, remote monitoring, digital sample tracking, and deeper integration of LIMS with enterprise systems.
Závěr
ALS provides a comprehensive, quality-centered platform for pharmaceutical testing, offering regulatory-aligned methodologies, advanced instrumentation, and global support to ensure reliable analytical outcomes.
Reference
- No external references were provided.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
WATER NEEDS IN PHARMA QUALITY CONTROL
2019|ELGA LabWater|Brochures and specifications
WATER NEEDS IN PHARMA QUALITY CONTROL Dedicated to Discovery WATER TECHNOLOGIES 2 Dedicated to Discovery Inside 3 Water and pharma 5 Water in drug production and QC 7 Water for manufacture of APIs 9 The role of water in QC…
Key words
water, waterdiscovery, discoverydedicated, dedicatedquality, qualityapi, apimicrobiological, microbiologicalfinal, finalpharmaceutical, pharmaceuticaldrug, drugpurification, purificationproduction, productionagency, agencyshould, shouldsops, sopswfi
Measuring Elemental Impurities in Pharmaceutical Materials
2022|Agilent Technologies|Brochures and specifications
Measuring Elemental Impurities in Pharmaceutical Materials Agilent Atomic Spectroscopy Solutions USP <232>/<233> & ICH Q3D(R2)/Q2(R1) Implementing Elemental Impurities Tests in the Pharmaceutical Industry Worldwide regulations for pharmaceutical materials Worldwide pharmacopeias have introduced revised standards for controlling elemental impurities in drug…
Key words
pde, pdequalification, qualificationelemental, elementalimpurities, impuritiesyou, youyour, yourcrosslab, crosslabagilent, agilentparenteral, parenteralcompliance, compliancecrms, crmsich, ichinhalational, inhalationalsoftware, softwarehave
USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution
2021|Agilent Technologies|Technical notes
White Paper USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution Elemental Impurity Analysis Requirements Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. To achieve this, potentially harmful contaminants—including elemental…
Key words
icp, icpoes, oespde, pdeelemental, elementalich, ichagilent, agilentusp, uspdrug, druginorganic, inorganicelements, elementspharmaceutical, pharmaceuticalimpurities, impuritiesrecords, recordsspeciation, speciationoral
USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution
2021|Agilent Technologies|Technical notes
White Paper USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution Elemental Impurity Analysis Requirements Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. Potentially toxic and harmful contaminants—including elemental impurities—must…
Key words
icp, icpelemental, elementalich, ichagilent, agilentpde, pdeusp, uspelements, elementslimits, limitspharmaceutical, pharmaceuticaldilution, dilutionimpurities, impuritiesmasshunter, masshunterdrug, drugdaily, dailysoftware